Catastrophic antiphospholipid syndrome

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 1-2, 2006, Pages

  Cervera, Ricard ^a   Asherson, Ronald A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome Antiphospholipid antibodies; Lupus anticoagulant

Indexed keywords

ANCROD; ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; DEFIBROTIDE; HEPARIN; IMMUNOGLOBULIN; PROSTACYCLIN; RITUXIMAB; STEROID;

ANTIPHOSPHOLIPID SYNDROME; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; INFECTION; LABORATORY TEST; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 33748441990     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093565     Document Type: Conference Paper

References (24)

1. Asherson RA. The catastrophic antiphospholipid antibody syndrome. J Rheumatol 1992; 19:508-12.
2. Piette JC, Cervera R, Levy R, Nasonov EL, Triplett DA, Shoenfeld Y. The catastrophic antiphospholipid syndrome - Asherson's syndrome. Ann Med Intern 2003; 154: 95-96.
3. Greisman SG, Thayaparan R-S, Godwin TA, Lockshin MD. Occlusive vasculopathy in systemic lupus erythematosus - Association with anticardiolipin antibody. Arch Intern Med 1991; 151: 389-392.
4. Harris EN, Bos K. An acute disseminated coagulopathy-vasculopathy associated with the antiphopholipid syndrome. Arch Intern Med 1991; 151: 231-232.
5. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, Lim K, Muñoz-Rodríguez FJ, Levy RA, Boué F, Rossert J, Ingelmo M. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77:195-207.
6. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-Góral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodríguez J, García-Carrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355-376.
7. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Mettrai PL, Derksen RHWM, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GRV, Ingelmo M on behalf of the "Euro-Phospholipid Project Group". Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-1027.
8. Cervera R, Font J, Tincani A, Boffa MC. V Meeting of the European Forum on Antiphospholipid Antibodies. Autoimmun Rev 2006 (in press).
9. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-534.
10. Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals, M, Ingelmo M, Piette JC, Shoenfeld Y, RA Asherson for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1205-1209.
11. Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - Molecular mimicry? J Rheumatol, 2000; 27: 12-14.
12. Gharavi E, Cucurull E, Tang H, Celli CM, Wilson WA, Gharavi AE. Induction of antiphospholipid antibodies by immunization with viral peptides. Lupus 1999; 8: 449-455.
13. Gharavi AE, Pierangeli SS, Harris N. New developments in viral peptides and antiphospholipid antibody induction. J Autoimmunity 2000; 15: 227-230.
14. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006; 65: 2-6.
15. Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J. Antiphospholipid antibodies associated with malignancies: Clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 2006 (in press).
16. Kitchens CS. Thrombotic storm: When thrombosis begets thrombosis. Am J Med 1998; 104: 381-385.
17. Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gómez-Puerta JA, Ramos-Casals M, Ingelmo M, Font J, for the Catastrophic Antiphospholipid Syndrome Registry Project Group. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006; 65: 81-86.
18. Asherson RA, Espinosa G, Cervera R, Gómez-Puerta JA, Musuraana J, Bucciarelli S, Ramos-Casals M, Martínez-González AL, Ingelmo M, Reverter JC, Font J, Triplett DA, for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 2005; 64: 943-946.
19. Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter JC, De la Red G, Gil V, Ingelmo M, Font J, Asherson RA. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730-736.
20. Undas A, Swadzba J, Undas R, Musial J. Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome. Pol Arch Med Wewn 1998; 100: 556-560.
21. Cerveny KC, Sawitzke AD. Relapsing catastrophic antiphospholipid antibody syndrome: A mimic for thrombotic thrombocytopenic purpura? Lupus 1999: 8: 477-481.
22. Gordon A, McLean CA, Ryan P, Roberts SK. Steroid-responsive catastrophic antiphospholipid syndrome. J Gastroenterol Hepatol. 2004; 19: 479-80.
23. Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, Font J, Asherson RA for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006 (in press).
24. Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, Lockshin MD for the Catastrophic Antiphospholipid Syndrome Registry Project Group. The long-term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 2003; 62: 530-533.